Volume: 25 Issue: 5

1. Characteristic and development of standard operating procedure of electronic data management in traditional Chinese medicine clinical research Page:550—554
2. Design and practice of clinical trial management information system Page:555—558
3. Effects of imipenem-cilastatin sodium combined with immunoglobulin on serum PCT, hs-CRP and TNF-α in children with baby sepsis complicated with disseminated intravascular coagulation Page:559—565
4. Therapeutic drug monitoring and pharmacokinetics of new coronavirus pneumonia antiviral drugs Page:566—575
5. Research progress in the mechanism of BRAF inhibitor resistance in melanoma Page:576—583
6. Research Progress of Pirfenidone for connective tissue disease-associated interstitial lung diseases Page:584—590
7. Clinical trials during post-COVID pandemic: An interim review Page:591—594
8. Research progress on the mechanism and treatment of pelvic organ prolapse Page:595—600
9. Protective effects of Xiaochaihu Decoction on chemical hepatic fibrosis in mice Page:481—488
10. miR-138-5p protects β cell function by regulating HIF-1α in gestational diabetes mellitus Page:489—497
11. Effects of pterostilbene on myocardial function, myocardial fibrosis and inflammatory response in rats with acute myocardial infarction and on Notch1/eIF3a signaling pathway Page:498—504
12. AHVAC- inhibits the proliferation in human primary gastric cancer cells Page:505—511
13. Yiqi Huoxue decoction inhibits malignant biological behavior of human lung cancer cells via the miR-21/PTEN signaling pathway Page:512—518
14. Lidocaine inhibits the malignant proliferation, invasion and regulates the mitochondrial respiration of osteosarcoma MG-63 cells Page:519—526
15. miR-106a regulates the proliferation of ovarian granulosa cells by targeting TIMP-2 Page:527—532
16. Lycium barbarum polysaccharide inhibits the proliferation and promots the apoptosis of osteosarcoma HOS cells by blocking Shh signaling pathway Page:533—539
17. Missed and remedial dosage regimens of erlotinib by Monte Carlo simulation Page:540—545
18. Discussion on the format and content of new drug population pharmacokinetic study report Page:546—549